These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
726 related articles for article (PubMed ID: 33579825)
1. METTL3-dependent N Chien CS; Li JY; Chien Y; Wang ML; Yarmishyn AA; Tsai PH; Juan CC; Nguyen P; Cheng HM; Huo TI; Chiou SH; Chien S Proc Natl Acad Sci U S A; 2021 Feb; 118(7):. PubMed ID: 33579825 [TBL] [Abstract][Full Text] [Related]
2. RNA Li B; Zhang T; Liu M; Cui Z; Zhang Y; Liu M; Liu Y; Sun Y; Li M; Tian Y; Yang Y; Jiang H; Liang D Elife; 2022 Jan; 11():. PubMed ID: 35001873 [TBL] [Abstract][Full Text] [Related]
3. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer. Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495 [TBL] [Abstract][Full Text] [Related]
4. Endothelial METTL3 (Methyltransferase-Like 3) Inhibits Fibrinolysis by Promoting PAI-1 (Plasminogen Activator Inhibitor-1) Expression Through Enhancing Jun Proto-Oncogene N6-Methyladenosine Modification. Bai Q; Lu Y; Chen Y; Zhang H; Zhang W; Wu H; Wen A Arterioscler Thromb Vasc Biol; 2021 Dec; 41(12):2877-2889. PubMed ID: 34645279 [TBL] [Abstract][Full Text] [Related]
5. METTL3/YTHDF2 m Xie H; Li J; Ying Y; Yan H; Jin K; Ma X; He L; Xu X; Liu B; Wang X; Zheng X; Xie L J Cell Mol Med; 2020 Apr; 24(7):4092-4104. PubMed ID: 32126149 [TBL] [Abstract][Full Text] [Related]
6. YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m Chai RC; Chang YZ; Chang X; Pang B; An SY; Zhang KN; Chang YH; Jiang T; Wang YZ J Hematol Oncol; 2021 Jul; 14(1):109. PubMed ID: 34246306 [TBL] [Abstract][Full Text] [Related]
7. METTL3 (Methyltransferase Like 3)-Dependent N6-Methyladenosine Modification on Li Q; Yu L; Gao A; Ren R; Zhang J; Cao L; Wang X; Liu Y; Qi W; Cai L; Li W; Wang W; Guo X; Su G; Yu X; Zhang J; Xi B; Zhang Y; Zhang M; Zhang C Arterioscler Thromb Vasc Biol; 2023 May; 43(5):755-773. PubMed ID: 36951060 [TBL] [Abstract][Full Text] [Related]
8. N6-methyladenosine modification of KLF2 may contribute to endothelial-to-mesenchymal transition in pulmonary hypertension. Kang K; Xiang J; Zhang X; Xie Y; Zhou M; Zeng L; Zhuang J; Kuang J; Lin Y; Hu B; Xiong Q; Yin Q; Su Q; Liao X; Wang J; Niu Y; Liu C; Tian J; Gou D Cell Mol Biol Lett; 2024 May; 29(1):69. PubMed ID: 38741032 [TBL] [Abstract][Full Text] [Related]
9. Dynamic m Yang F; Jin H; Que B; Chao Y; Zhang H; Ying X; Zhou Z; Yuan Z; Su J; Wu B; Zhang W; Qi D; Chen D; Min W; Lin S; Ji W Oncogene; 2019 Jun; 38(24):4755-4772. PubMed ID: 30796352 [TBL] [Abstract][Full Text] [Related]
10. METTL3 Modulates Osteoclast Differentiation and Function by Controlling RNA Stability and Nuclear Export. Li D; Cai L; Meng R; Feng Z; Xu Q Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121289 [TBL] [Abstract][Full Text] [Related]
11. RNA m Lin Z; Niu Y; Wan A; Chen D; Liang H; Chen X; Sun L; Zhan S; Chen L; Cheng C; Zhang X; Bu X; He W; Wan G EMBO J; 2020 Jun; 39(12):e103181. PubMed ID: 32368828 [TBL] [Abstract][Full Text] [Related]
12. Endothelial UCP2 Is a Mechanosensitive Suppressor of Atherosclerosis. Luo JY; Cheng CK; He L; Pu Y; Zhang Y; Lin X; Xu A; Lau CW; Tian XY; Ma RCW; Jo H; Huang Y Circ Res; 2022 Aug; 131(5):424-441. PubMed ID: 35899624 [TBL] [Abstract][Full Text] [Related]
13. Flow-dependent epigenetic DNA methylation regulates endothelial gene expression and atherosclerosis. Dunn J; Qiu H; Kim S; Jjingo D; Hoffman R; Kim CW; Jang I; Son DJ; Kim D; Pan C; Fan Y; Jordan IK; Jo H J Clin Invest; 2014 Jul; 124(7):3187-99. PubMed ID: 24865430 [TBL] [Abstract][Full Text] [Related]
14. METTL3 regulates alternative splicing of MyD88 upon the lipopolysaccharide-induced inflammatory response in human dental pulp cells. Feng Z; Li Q; Meng R; Yi B; Xu Q J Cell Mol Med; 2018 May; 22(5):2558-2568. PubMed ID: 29502358 [TBL] [Abstract][Full Text] [Related]
15. METTL3/METTL14 Transactivation and m Feng Y; Dong H; Sun B; Hu Y; Yang Y; Jia Y; Jia L; Zhong X; Zhao R Cell Mol Gastroenterol Hepatol; 2021; 12(3):839-856. PubMed ID: 33992834 [TBL] [Abstract][Full Text] [Related]
16. METTL3-mediated N Zang Y; Tian Z; Wang D; Li Y; Zhang W; Ma C; Liao Z; Gao W; Qian L; Xu X; Jia J; Liu Z Oncogene; 2024 Jul; 43(30):2338-2354. PubMed ID: 38879589 [TBL] [Abstract][Full Text] [Related]
17. The N Dorn LE; Lasman L; Chen J; Xu X; Hund TJ; Medvedovic M; Hanna JH; van Berlo JH; Accornero F Circulation; 2019 Jan; 139(4):533-545. PubMed ID: 30586742 [TBL] [Abstract][Full Text] [Related]
18. m6A-related bioinformatics analysis and functional characterization reveals that METTL3-mediated NPC1L1 mRNA hypermethylation facilitates progression of atherosclerosis via inactivation of the MAPK pathway. Zhang G; Li X; Huang X Inflamm Res; 2023 Mar; 72(3):429-442. PubMed ID: 36583755 [TBL] [Abstract][Full Text] [Related]
19. METTL3 Regulates Osteoblast Differentiation and Inflammatory Response via Smad Signaling and MAPK Signaling. Zhang Y; Gu X; Li D; Cai L; Xu Q Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31892163 [TBL] [Abstract][Full Text] [Related]
20. N6-methyladenosine-driven miR-143/145-KLF4 circuit orchestrates the phenotypic switch of pulmonary artery smooth muscle cells. Kang K; Sun C; Li H; Liu X; Deng J; Chen S; Zeng L; Chen J; Liu X; Kuang J; Xiang J; Cheng J; Liao X; Lin M; Zhang X; Zhan C; Liu S; Wang J; Niu Y; Liu C; Liang C; Zhu J; Liang S; Tang H; Gou D Cell Mol Life Sci; 2024 Jun; 81(1):256. PubMed ID: 38866991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]